Search

everythinglearnresearchcommunity

for

Search:↓

Betulinic acid can help treat hepatitis C by stopping virus replication.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Provenge extends prostate cancer survival by about 4 months.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Promising cancer treatments were found, but the manufacturer closed.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

The treatment was effective for advanced non-Hodgkin's lymphomas.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

FGF-2&D/P nanoparticles can help treat hair loss.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.